Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 13 965 / https://doi.org/10.3332/ecancer.2019.965

Case Report

A case of Warthin-like papillary thyroid carcinoma with diffuse sclerosing stroma and a novel RET mutation: a new entity or a combined tumour?

Activating mutations of the RET gene have been described for both papillary (chromosomal rearrangement) and medullary (missense mutations) thyroid carcinomas. Here, we describe a case of a Warthin-like variant of papillary thyroid carcinoma displaying some morphological aspects that mimic the diffuse sclerosing variant. The tumour harboured BRAF V600E mutation and a novel germline point mutation in the RET gene, with unknown clinical and pathological meaning.

Keywords: RET, BRAF, thyroid carcinoma, mutation, pathology

Loading Article Metrics ... Please wait

Related articles

Short Communication: Elimination of cervical cancer: challenges for developing countries

Abstract | Full Article | PDF Published: 12 Nov 2019 / https://doi.org/10.3332/ecancer.2019.975

Review: Barriers to the composition and implementation of advance directives in oncology: a literature review

Abstract | Full Article | PDF Published: 12 Nov 2019 / https://doi.org/10.3332/ecancer.2019.974

Research: Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?

Abstract | Full Article | PDF Published: 04 Nov 2019 / https://doi.org/10.3332/ecancer.2019.973

Case Report: Common B-cell acute lymphoblastic leukaemia in a 70-year-old woman presenting 2 years after carboplatin-taxane radiotherapy for endometrial cancer

Abstract | Full Article | PDF Published: 29 Oct 2019 / https://doi.org/10.3332/ecancer.2019.972

Clinical Study: Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer

Abstract | Full Article | PDF Published: 29 Oct 2019 / https://doi.org/10.3332/ecancer.2019.971



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation